Thursday September 9, 2010
Aseptic Processing Operation
in the Manufacture of Biotech and Pharmaceutical Products
April 26-27, 2010 - Philadelphia, PA

A Two-day comprehensive course with interactive case studies & workshops covering a wide range of topics including:

  • Regulatory requirements and reality
  • Sterility testing and current industry issues
  • Key strategies to manage aseptic operations
  • Sterility sampling program
  • Compendial requirements for media and incubation
  • Interpreting sterility test results
  • Sterilization Principles
  • Common methods of sterilization; Terminal sterilization, Steam sterilization, Autoclaves, Dry heat and radiation, Chemical/EtO, and  Lyophilization
  • Establishing sterilization process cycles
  • Alternative methods of aseptic processing
  • Sterilizer qualification and validation
  • Investigating sterility failures
  • Trending of sterility tests results
  • Common causes for sterility failures

Case studies:

  • Conducting a media fill failure investigation  

Interactive workshop:

  • Aseptic processing equipment:
  • Project management for Design, Procurement, Acceptance Testing and Qualification
Mr. Martell K. Winters, B.S. RM/SM (NRM)
Senior Scientist
Nelson Laboratories Inc.

Martell Winters B.S. RM/SM (NRM), is currently a senior scientist at Nelson Laboratories, Inc. In addition to being the AATB liaison to the AAMI Radiation Working Group, Martell also participates in multiple task forces from the AAMI working group organized to draft new procedures (e.g. VDmax, sterilization of tissue).

Martell has presented at AATB meetings as well as national and international conferences (IMRP, IAEA) regarding microbiological culturing, bioburden, radiation sterilization, and sterility assurance levels.

Martell was responsible for the development of the AAMI TIR on Radiation Sterilization of Human Tissue-based Products and is currently involved in developing the ISO standard on Aseptic Processing of Solid Medical Devices. He has assisted the International Irradiation Association (iiA) in preparing a seminar on radiation sterilization of small and large molecules.


Dr. Carolyn Broughton
Scientist
Technology & Methods Management
Genetech, Inc
 

Carolyn Broughton, PhD, is currently a Scientist in Technology & Methods Management at Genentech, Inc. Her responsibilities include collaborative and contract projects for both clinical and commercial products. She has more than twenty years experience managing microbiology laboratories in the biotechnology, pharmaceutical and cosmetics industries. She received her PhD in Microbiology from North Carolina State University.


Mr. Kenneth Christie
Chief Operating Officer
VTS Consultants

Kenneth Christie has over 30 years of sterile manufacturing and regulatory consulting experience in the areas of Quality Assurance and Validation Management in the pharmaceutical and biotechnology industries. Mr. Christie is currently the Chief Operating Officer for VTS Consultants, Inc located in Amhesrt, MA. Specifically, his responsibilities include quality system auditing, GMP training, and serving as a subject matter expert for aseptic and solid dosage processing equipment, utilities, and systems on a global basis.

Prior to joining VTS, Mr. Christie was the Validation Manager at Parke-Davis' Sterile Products Facility in Rochester, MI. While there, he was involved in the review and approval of all facility, equipment, and system commissioning/qualification activities. Additional responsibilities included routine interaction with the FDA and European inspectors, corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products.

Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, Mr. Christie serves as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member.

He possesses a BS degree in Biology from Shippensburg State University (PA) and an Executive MBA degree from Michigan State.


Mr. Austin McDonald
Sr. Engineer
Project Manager
Sterile Technology LLC

Austin McDonald is a Sr. Engineer / Project Manager at Sterile Technology LLC, located in Wilmington Delaware. With 20 years in the pharmaceutical industry, Austin has extensive experience supporting clients in the design, construction, qualification and operation of sterile manufacturing processes and facilities. Austin’s specialist areas are Regulatory & Quality, manufacturing operations, barrier isolator systems, sterilization (H2O2, steam & gamma), sterile component handling, sterile filling of vials & syringes, lyophilization & loading systems, automated inspection systems and the handling of complex materials including, cytotoxic substances, carcinogenic substances, biological hazards & radioactive pharmaceuticals. In addition to speaking at numerous conferences on aseptic processing and isolation technology, Austin is an Adjunct Professor at Stevens Institute of Technology, NJ, where he lectures on the project management, design and implementation of advanced aseptic processes. Prior to Sterile Technology, Austin was a Principal Engineer and Managing Partner at GL Engineering, Livingston NJ, Director of Barrier Technology at Kvaerner Process, Bridgewater NJ, and a Director at the Tanshire Group, Elstead, Surrey, UK (now Bovis Lend Lease).


Mr. Jim Polarine Jr., MA.
Formulated Chemistries
Technical Service Specialist
STERIS Corporation

Mr. Polarine is a technical service specialist at STERIS Corporation. He has been with STERIS Corporation for over nine years, where his current technical focus is microbial control in cleanrooms and other critical environments. He has lectured in North America, Europe, Asia, Latin America, and Puerto Rico on issues related to cleaning and disinfection in cleanrooms. Mr. Polarine is a frequent industry speaker and has worked on several books and article publications related to cleaning and disinfection and contamination control. He is currently co-authoring several articles and is an author on the PDA technical report on cleaning and disinfection. He is also currently active on the PDA task force on cleaning and disinfection. He is part of the faculty at the University of Tennessee Parenteral Medication course. He has presented at key industry events for PDA, ISPE, AALAS, IVT, University of Tennessee, SWE, and Barnett International on cleaning and disinfection and contamination control. Mr. Polarine also frequently presents global industry webinars on Cleaning and Disinfection including one that he co-presents with Carole Genovesi (Cleanroom Manager at Genentech). Mr. Polarine graduated from the University of Illinois with a Master of Arts in Biology, and is a member of the PDA, ISPE, IEST, ASM, AALAS, ASTM, AAAS, AOAC, and ACS. He previously worked as a clinical research coordinator with the Department of Veteran’s Affairs and as a biology and microbiology instructor at the University of Illinois. His main hobby is storm chasing and is very active in tornado research and tornado safety.

Monday April 26, 2010
08:00 AM Registration and Continental Breakfast
08:30 AM Risk Management Basics (ISO 31000)
10:45 AM Mid-Morning Refreshment Break
11:00 AM Course Continues
12:30 AM Luncheon
1:45 PM Course Continues
2:45 PM Mid-Afternoon Refreshment
3:00 PM Course Continues
5:00 PM Questions & Answers
5:15 PM Conclusion of Day 1
   
Tuesday April 27, 2010
8:00 AM Continental Breakfast
8:30 AM Course Continues
10:00 AM Mid-Morning Refreshment Break
10:15 AM Course Continues
12:30 PM Luncheon
1:30 PM Course Continues
2:45 PM Mid-Afternoon Refreshment Break
3:00 PM Course Continues
5:30 PM Questions & Answers
5:45 PM Conclusion of Program
   
Course Content
The Basics of Aseptic Processing…and How Best to Manage Them
  • Review the Current Regulatory requirements for aseptic processing
  • Learn the major areas of focus during regulatory inspections.
  • Discuss most common deficiencies cited by the FDA
Sterility Testing Programs – Regulatory Requirements and Reality
  • Purpose of sterility testing and current industry issues
  • Steps for establishing a sterility sampling program
  • Common causes for sterility failures; equipment, procedures, and personnel
  • Compendial requirements for media and incubation
  • Interpreting sterility test results
  • Product disposition issues: when is retesting justified?
Defining Common Methods of Sterilization
  • Review the basics of Sterilization Principles, such as D-values, Fₒ, sterility assurance levels (SAL) and regulatory requirements for sterilization.
  • Discuss Common methods of sterilization; Terminal sterilization, Steam sterilization, Autoclaves, Dry heat, Chemical/EtO, and the advantages and differences between them.
  • Review common deficiencies cited by inspectors regarding sterilization processes.
Sterilization practices for drugs, devices and lab research markets
  • High temperature
  • Gas/vapor
  • Radiation
  • Mechanical
  • Chemical

Sterility assurance monitoring tools and practices

  • Chemical indicators
  • Biological indicators
Investigating sterility failures
  • Sterility Testing
  • Compendial requirements
  • Limitations of the method
  • Interpretation of results
  • Elements of investigation: Quality and Manufacturing sites
    • Facilities/Equipment
    • Personnel/Training
  • Unusual events
  • Assessing impact
  • Corrective and preventive actions
  • Consequences
Fundamentals of Sterilization Validation
  • Review the requirements for Establishing sterilization process cycles
  • Understand the basics of Sterilizer qualifications and review the information required in validation protocols (IQ/OQ and PQ)
  • Review the typical information expected in sterilization procedures and the areas of focus during an audit.
Strategies for Investigating Sterility Failures for Regulated Manufacturing Facilities
  • The importance of trending results of sterility tests
  • Laboratory failure investigations
  • Using Corrective and Preventative Action Plans (CAPAs)
  • Conducting manufacturing OOS investigations
  • Common deficiencies associated with OOS investigations
  • Items to implement for avoiding and/or preparing for a failure
Conducting a media fill failure investigation
  • Guidance documents
  • Media fill study design
    • Worst case conditions
    • Interventions
  • Discrepancy Systems
  • Policies
  • Roles and responsibilities
  • Documentation
  • Investigation
    • Facility: cleaning and monitoring
    • Equipment: sanitization and sterilization
    • Personnel: training and qualification
    • Interpretation of data
    • Corrective and preventive actions

Interactive Exercise: The group will analyze data from a failed media fill, develop an investigation plan, and propose corrective actions.

Aseptic Processing Equipment

This presentation will outline the considerations when selecting equipment and suppliers for aseptic processing process equipment for aseptic vial filling / lyophilization & inspection and aseptic syringe filling & inspection.

  • The importance of correctly defining aseptic filling process capacity requirements accurately
    • Understanding product characteristics & how subtle product characteristics can fundamentally affect the selection of equipment
    • The effect of aseptic filling equipment selection on component preparation
    • The effect of aseptic filling equipment complexity and speed on reliability
    • How the approach to the design and implementation of aseptic process equipment can affect unit cost
  • Selecting the equipment vendors
    • The competitive bid process
  • Integrating equipment design considerations with equipment validation considerations
  • Selecting the processing environment for an aseptic process
    • Traditional clean room
    • RABS
    • Barrier isolation technology
  • Selecting filling technology
    • Positive displacement
    • Time pressure filling
    • Peristaltic filling
  • Common design considerations for all aseptic processing equipment
  • Specific design considerations for aseptic vial filling / lyophilization equipment
    • Vial washing
    • Vial depyrogenation
    • Vial filling
    • Lyophilizer loading systems
    • Lyophilizers
    • Vial capping
    • Equipment layout issues
  • Specific design considerations for aseptic syringe filling equipment
    • Syringe component handling / transfer
    • Syringe filling
    • Equipment layout issues
  • Selecting vial & syringe inspection equipment
  • Documentation
    • What are important documents
    • Who is best suited to generating documents (the supplier or the customer)
Design, Procurement, Acceptance Testing And Qualification Of Aseptic Processing Equipment

This presentation will outline the key steps associated with the design, procurement, acceptance testing and qualification of aseptic processing equipment undertaken within a modified GAMP structure, and how this methodology is used to help minimize the technical challenges, cost and schedule overruns typically associated with implementing complex aseptic manufacturing processes. This presentation will address the following:

  • The GMP Project Management Philosophy
    • What are the drivers for GMP project management
  • What Is The Value Of GMP Project Management?
  • The Objectives Of GMP Project Management
    • Management of equipment technical risk
    • Maintenance of the project budget & schedule
    • Ensuring total control of the equipment from equipment procurement to hand over to operations
    • Meeting regulatory expectations
  • The GMP Project Management Approach
    • Summary of the key project steps from defining capacity requirements to hand over to operations
    • What are the key project documents and where do the URS / FS / HDS / SDS fit in
    • How to prepare the equipment procurement documentation
    • How to manage the Vendor, the technical issues, cost issues and the integration of the equipment into the facility
    • Factory acceptance testing preparation & execution
    • Transition to validation from engineering using site acceptance testing
    • Validation
  • Typical Project Pitfalls
    • Typical project pitfalls will be discussed, and how these pits falls can be avoided using GMP project management

This two day course and workshops is directed toward Directors, Managers, Supervisors, Analysts and Associates in the Pharmaceutical, Biopharmaceutical, Biotechnology and allied industries with daily responsibilities in the following areas:

  •  Regulatory Affairs
  •  Quality Assurance
  •  Quality Compliance
  •  Submissions Management
  •  Documentation
  •  Medical Writing
  •  R&D
  •  IT Systems
  •  Validation
  •  Electronic Publishing
  •  Project Management
  •  Records Management
  •  Medical and Clinical Affairs
  •  CMC

Special group rates available for three or more registrants. Some restriction applies.

Take advantage of this unique opportunity to participate in a shared learning environment and find expert solutions

3 easy ways to register!
Mail:
International Pharmaceutical Academy
420 Highway# 7 East, Box 82022
Richmond Hill, Ontario
Canada L4B 3K0
Fax:
(905) 472-1819

Please fill out the form below and your registration will be processed as soon as possible.

Online Registration:
First Name:
Last Name:
Job Title/Position:
Company:
Address:
City:
Province/State:
Postal Code/ZIP:
Country:
Phone Number:
Fax Number:
Email:
ATTENDEE's Email:

Please register the following delegate(s) for:

Event Name: Registration fee:
Aseptic Processing Operations - Philadelphia USD $895.00
Payment Methods (Please check payment method):
Cheque(s)
- Please make your cheque payable to: "International Pharmaceutical Academy Inc. "
Company P.O.
- Please bill my company P.O.#
  Credit Card option (- Please contact me for Credit Card information)
Visa
Mastercard
Promotion Code:
 

 

Registration Fee Includes: Presentation Materials, Luncheon, and Refreshments

Cancellation/Substitutions Policy:

All cancellations are subject to a USD $150.00/person processing fee. To receive cancellation credits for attendance at an upcoming course, IPA must be notified of the cancellation in writing (by email, mail or fax) up to 3 weeks prior to the program start date. Cancellations submitted less than 3 weeks prior to the event will not be qualified for refund or credit. Substitution of delegate/s with the member/s of the same organization is permitted at any time with no penalty.

IPA reserves the right to postpone an event, prior to which time all the registered attendees will be notified a minimum of 2 weeks in advance. IPA shall not be responsible for any air fare, hotel or transportation costs incurred by registrant/s.

 

Hilton Philadelphia Airport

4509 Island Avenue, Philadelphia,
Pennsylvania, United States 19153

Tel: 1-215-365-4150 Fax: 1-215-937-6382

Copyright © 2010 www.ipacanada.com - International Pharmaceutical Academy - All Rights Reserved.